Ticagrelor Market 2026–2035 expanding with cardiovascular treatment demand

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Ticagrelor Market During 2026–2030?

The ticagrelor market has experienced robust expansion in recent years. Its size is anticipated to climb from $1.93 billion in 2025 to $2.08 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. This past growth can be ascribed to a limited selection of antiplatelet therapies, the increasing prevalence of cardiovascular disease, the expansion of hospital pharmacy networks, a rise in clinical trials for cardiovascular drugs, and enhanced awareness regarding the risks of heart attack and stroke.

The ticagrelor market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $2.75 billion, demonstrating a compound annual growth rate (CAGR) of 7.3%. This projected growth during the forecast period is fueled by several factors, including the introduction of extended-release ticagrelor tablets, the broadening reach of retail and online pharmacy channels, a growing embrace of individualized cardiovascular treatment, escalating governmental efforts for preventing cardiovascular diseases, and the incorporation of digital health monitoring systems. Key trends expected throughout the forecast horizon involve the increasing application of ticagrelor in managing acute coronary syndrome, a developing preference for oral antiplatelet treatments over injectable alternatives, the expansion of both hospital and ambulatory cardiology provisions, enhanced public understanding regarding stroke and myocardial infarction prevention, and the ongoing creation of extended-release ticagrelor formulations.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24726&type=smp

What Drivers Are Expected To Influence The Ticagrelor Market During The Forecast Period?

The expanding occurrence of cardiovascular diseases is anticipated to fuel the expansion of the ticagrelor market in the future. These diseases encompass various ailments impacting the heart and blood vessels, such as coronary heart disease, heart failure, stroke, and hypertension. The rising incidence of cardiovascular diseases largely stems from unhealthy eating habits, given that overconsumption of saturated fats, trans fats, added sugars, and sodium leads to high blood pressure, obesity, and elevated cholesterol levels, all significant risk factors for cardiac ailments. Ticagrelor aids in managing cardiovascular diseases by inhibiting platelet aggregation, thereby lowering the likelihood of blood clot formation. This medication enhances patient outcomes by decreasing the probability of heart attacks and strokes, particularly for those at elevated risk. As an illustration, data from January 2024, published by the American Heart Association, a US-based non-profit organization, showed that the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, marking a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the growing occurrence of cardiovascular diseases is propelling the expansion of the ticagrelor market.

How Are The Various Segments Of The Ticagrelor Market Categorized?

The ticagrelor market covered in this report is segmented –

1) By Type: 90 mg Tablet, 60 mg Tablet

2) By Drug Class: Antiplatelet Agents, Antithrombotic Agents

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By Application: Acute Coronary Syndrome, Myocardial Infarction, Stroke Prevention, Other Applications

5) By End User: Hospitals And Clinics, Ambulatory Centers, Other End Users

What Trends Are Affecting The Expansion Of The Ticagrelor Market?

Leading companies within the ticagrelor market are concentrating on securing regulatory clearances to expand product applications, improve market reach, and strengthen their competitive position. Such regulatory approvals signify the official consent granted by governmental bodies for the marketing and sale of a product, confirming its compliance with safety, efficacy, and quality benchmarks. For example, in May 2025, Alembic Pharmaceuticals Ltd., an Indian pharmaceutical company, was granted an abbreviated new drug application (ANDA) by the US Food & Drug Administration (USFDA) for its generic ticagrelor tablets 90 mg, and also received tentative approval for the 60 mg strength. These tablets are utilized to lower the risk of cardiovascular events, operating by inhibiting platelet aggregation and thus preventing blood clot formation.

Which Major Firms Influence Developments In The Ticagrelor Market?

Major companies operating in the ticagrelor market are AstraZeneca PLC, Merck KGaA, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Limited, Cadila Pharmaceuticals Limited, Alkem Laboratories, Alembic Pharmaceuticals Limited, CCL Pharmaceuticals, Neuland Laboratories, Jiangxi Synergy Pharmaceutical Co. Ltd., Leeford Healthcare Limited, Scimplify, JAMP Pharma Corporation, Actoverco Pharmaceutical Company, CTX Lifesciences Private Limited, DM Pharma, Hema Pharmaceuticals Pvt. Ltd., Chia-Tai Tianqing Pharmaceutical Group Co. Ltd., Biophar Lifesciences Pvt. Ltd., PhaseBio Pharmaceuticals Inc.

Read the full ticagrelor market report here:

https://www.thebusinessresearchcompany.com/report/ticagrelor-global-market-report

Which Region Is Forecast To Lead The Ticagrelor Market In Terms Of Market Size?

North America was the largest region in the ticagrelor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ticagrelor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Ticagrelor Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24726&type=smp

Browse Through More Reports Similar to the Global Ticagrelor Market 2026, By The Business Research Company

Induced Pluripotent Stem Cell Market Report 2026

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

Cell Based Assays Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Stem Cell Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795